Find out what the numbers really say — before the market does
Analyze now
News Sentiment
Are today's headlines a buy signal or a red flag?
Analyze now
Buy / Hold / Sell
Should you Buy, Hold, or Sell? Get the AI verdict now.
Analyze now
Risk Assessment
Uncover hidden risks before they hit your portfolio.
Analyze now
Fair Value
Is this stock cheap, fairly priced, or overvalued?
Analyze now
Latest AI Analyses of INVESCO S&P 500 EQUAL WEIGHT INDUSTRIALS PORTFOLIO
No Price
28.04.2026 20:00
Current Prices from INVESCO S&P 500 EQUAL WEIGHT INDUSTRIALS PORTFOLIO
Exchange
Ticker
Currency
Last Trade
Price
Daily Change
UTC
RGIN
USD
28.04.2026 20:00
0,0001 USD
0,00 USD
Company Profile for INVESCO S&P 500 EQUAL WEIGHT INDUSTRIALS PORTFOLIO Share
Regenicin, Inc. focuses on developing and commercializing a technology of tissue-engineered skin substitutes. The company's product portfolio includes NovaDerm, a multi-layered tissue-engineered living skin and cultured skin substitute product for the treatment of burns; and TempaDerm to treat smaller wound areas on patients, such as ulcers. Its products are used to restore the qualities of healthy human skin for use in the treatment of burns, chronic wounds, and various plastic surgery procedures. The company was formerly known as Windstar, Inc. and changed its name to Regenicin, Inc. in July 2010. Regenicin, Inc. was incorporated in 2007 and is headquartered in Little Falls, New Jersey.
